SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-08-033737
Filing Date
2008-06-05
Accepted
2008-06-05 07:01:01
Documents
4
Period of Report
2008-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v116585_8k.htm 8-K 31248
2 v116585_ex99-1.htm EX-99.1 19532
3 GRAPHIC labcorplogo.jpg GRAPHIC 167056
4 GRAPHIC vandalogo.jpg GRAPHIC 55073
  Complete submission text file 0001144204-08-033737.txt   358654
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51863 | Film No.: 08881916
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1